Method Robustness and Transferability for Modern  Size-Exclusion Methods 
Helen Whitby, PhD 
Senior Product Manager – Bioseparations, Phenomenex
Tuesday November 7, 2023
10:00 AM - 11:00 AM (PT)
Key Learning Points:
  • Understand the impact of HPLC/UHPLC systems, including bio-inert and traditional stainless-steel configurations
  • Learn how to transition from a legacy SEC method to improve analytical method throughput and data quality 
  • Determine the experimental parameters to vary to ensure demonstration of analytical method robustness 
Who Should Attend:
  • Any scientists who are looking to learn more about method parameters and variables to consider for developing a robust and transferable method.
Speaker Bios:
Dr. Helen Whitby is the senior product manager for biopharma at Phenomenex. Helen has been with Phenomenex since 2007, starting in the UK sales team as a bulk and prep specialist before joining the technical team in 2016. Helen spent 6 years as a biopharma specialist in the technical team supporting all our biopharma products globally before moving to product management in 2022. Helen has a PhD from the University of Manchester working on analogues of Shikimic acid to treat malaria. Prior to joining Phenomenex, Helen spent a year as a Post-doctoral researcher at the University of Illinois in Chicago, where she studied electron-deficient divalent reactive intermediates, specifically nitrenium ions for the development of antiviral agents to treat Ebola.

Get a quote, method consultation, or further information about products to support your chromatography...

By submitting your information, you agree that Phenomenex may collect and process your personal data in accordance with its privacy policy. You also agree that Phenomenex may send you marketing communications. You can unsubscribe from receiving additional information at any time.